MYO5A and hemophagocytic syndrome: In GS1, primary neurological impairments stem from the pivotal role of myosin Va in neuronal development, neuropeptide exocytosis, and synaptic plasticity, whereas in GS2, neurological manifestations result from lymphohistiocytic hemophagocytosis (HLH).